National Health Council Statement on Nomination of Dr. Scott Gottlieb as FDA Commissioner

Washington, DC (April 5, 2017) - National Health Council Statement on Nomination of Dr. Scott Gottlieb as FDA Commissioner

The following statement is from NHC’s Chief Executive Officer, Marc Boutin:

"The National Health Council (NHC) supports the nomination of Dr. Scott Gottlieb as Commissioner of the U.S. Food and Drug Administration (FDA). Dr. Gottlieb’s experience as a patient, as well as being a former Deputy Commissioner of the FDA and Senior Advisor to the Administrator of the Centers for Medicare and Medicaid Services (CMS), uniquely qualify him for the position. Based on our previous work together, we know Dr. Gottlieb has a long-standing commitment to bringing the voice of the patient into the medical product development process and look forward to his leadership in this area. We urge the Senate to swiftly approve his nomination."

Founded in 1920, the NHC is the only organization that brings together all segments of the health community to provide a united voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers. Made up of more than 100 national healthrelated organizations and businesses, the NHC's core membership includes the nation’s leading patient advocacy organizations, which control its governance and policy-making process. Other members include professional and membership associations, nonprofit organizations with an interest in health, and representatives from the pharmaceutical, generic drug, insurance, medical device, and biotechnology industries.